Plain-English translation of NCT06678828 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new blood test called ClarityDX Prostate that may help your doctors decide whether you need further testing or a biopsy for prostate cancer. The goal is to avoid unnecessary procedures in men at low risk while making sure men at high risk get the care they need promptly.
Right now, doctors sometimes order imaging tests and biopsies that turn out not to be necessary, which can cause worry and extra healthcare visits. This trial wants to see if the new blood test can help doctors be smarter about who really needs these additional tests.
You will have the blood test run as part of your initial evaluation. Depending on which group you're randomly assigned to, either your doctors will see the test results right away to help guide their recommendations, or the results will be kept hidden for about 12 months while your care follows standard guidelines. Either way, your doctors will decide what additional tests or procedures you need based on their clinical judgment. You'll have a follow-up visit around 12 months to check on your results and care.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Canada